Mary Eapen

Professor

Medical College of Wisconsin

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mary Eapen is a Professor at the Medical College of Wisconsin, USA. Her research areas include hematopoietic cell transplant, gene therapy for hemophilia, and the treatment and outcomes of sickle cell disease and aplastic anaemia. She has contributed significantly to understanding long-term survival and donor selection in hematopoietic cell transplantation.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Robert Peter Gale

Imperial College London

UNITED KINGDOM

View details

Larisa Broglie

Assistant Professor

Medical College of Wisconsin

UNITED STATES

View details

Mark Walters

Professor

UCSF Benioff Children's Hospital

UNITED STATES

View details

Soyoung Kim

Associate Professor

Medical College of Wisconsin

UNITED STATES

View details

Fuad El Rassi

Emory University

UNITED STATES

View details

Christopher McKinney

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Christopher Dvorak

University of California, San Francisco

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mary Eapen

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease

Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History

Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study

Choosing donors in clinical practice

Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease

One’s expectations for normality

What causes aplastic anaemia?

Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease

To treat with curative intent or modify disease?

Reply to R. Meisel

Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders

Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012

Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population

Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia

Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes

Collaborators (7)

Robert Peter Gale

Larisa Broglie

Mark Walters

Soyoung Kim

Fuad El Rassi

Christopher McKinney

Christopher Dvorak

Make your next move.